Valuation Joinn Laboratories(China)Co.,Ltd.
Stocks
603127
CNE100002W27
Biotechnology & Medical Research
|
End-of-day quote
Shanghai S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 49.30 CNY | +10.00% |
|
+6.27% | +40.82% |
| 09-24 | Joinn Laboratories' Unit Subscribes to Asset Management Products for 540 Million Yuan | MT |
| 08-28 | Joinn Laboratories' H1 Attributable Profit Surges; Revenue Up | MT |
Company Valuation: Joinn Laboratories(China)Co.,Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 40,246 | 29,328 | 16,313 | 11,374 | 23,924 | 33,681 | - | - |
| Change | - | -27.13% | -44.38% | -30.28% | 110.35% | 40.78% | - | - |
| Enterprise Value (EV) 1 | 36,161 | 26,442 | 13,478 | 10,430 | 23,032 | 31,795 | 31,559 | 31,119 |
| Change | - | -26.88% | -49.03% | -22.61% | 120.83% | 38.05% | -0.74% | -1.39% |
| P/E | 76.4x | 29.2x | 44.7x | 166x | 87.5x | 40.5x | 61.5x | 43.7x |
| PBR | 6.16x | 3.82x | 2.15x | 1.54x | 3.15x | 4.14x | 3.99x | 3.74x |
| PEG | - | 0.3x | -0.7x | -2x | 0x | 0x | -1.8x | 1.1x |
| Capitalization / Revenue | 26.5x | 12.9x | 6.86x | 5.64x | 14.4x | 18.2x | 15.9x | 13.4x |
| EV / Revenue | 23.8x | 11.7x | 5.67x | 5.17x | 13.9x | 17.2x | 14.9x | 12.4x |
| EV / EBITDA | 50x | 19.8x | 21.5x | 48.8x | 46x | 143x | 75.3x | 40.6x |
| EV / EBIT | 56.2x | 21.6x | 26.6x | 152x | 68x | 30.4x | 47x | 50x |
| EV / FCF | 80.6x | 38x | 31.3x | 153x | 76.5x | 38x | 110x | 146x |
| FCF Yield | 1.24% | 2.63% | 3.19% | 0.65% | 1.31% | 2.63% | 0.91% | 0.68% |
| Dividend per Share 2 | 0.1837 | 0.2857 | 0.16 | 0.03 | 0.12 | 0.34 | 0.165 | 0.25 |
| Rate of return | 0.31% | 0.68% | 0.67% | 0.18% | 0.34% | 0.69% | 0.33% | 0.51% |
| EPS 2 | 0.7704 | 1.429 | 0.53 | 0.1 | 0.4 | 1.216 | 0.8017 | 1.128 |
| Distribution rate | 23.8% | 20% | 30.2% | 30% | 30% | 28% | 20.6% | 22.2% |
| Net sales 1 | 1,517 | 2,268 | 2,376 | 2,018 | 1,658 | 1,850 | 2,117 | 2,518 |
| EBITDA 1 | 723.1 | 1,333 | 626.1 | 213.9 | 500.7 | 222.1 | 419.3 | 766.5 |
| EBIT 1 | 643 | 1,226 | 507.1 | 68.81 | 338.9 | 1,046 | 671.7 | 622.6 |
| Net income 1 | 557 | 1,074 | 397 | 74.08 | 297.8 | 767 | 407.9 | 930.8 |
| Net Debt 1 | -4,085 | -2,886 | -2,835 | -943.6 | -891.7 | -1,886 | -2,122 | -2,562 |
| Reference price 2 | 58.89 | 41.72 | 23.71 | 16.63 | 35.01 | 49.30 | 49.30 | 49.30 |
| Nbr of stocks (in thousands) | 747,243 | 749,950 | 746,974 | 733,989 | 733,375 | 733,375 | - | - |
| Announcement Date | 2/24/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 40.55x | 17.19x | 198.78x | 0.69% | 5.02B | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 22.93x | 29.95x | 31.10x | 0.35% | 39.56B | |
| Weighted average by Cap. | 22.50x | 31.85x | 15.90x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 603127 Stock
- Valuation Joinn Laboratories(China)Co.,Ltd.
Select your edition
All financial news and data tailored to specific country editions
